
AOD9604
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
AOD9604 ist ein modifiziertes Fragment, das der C-terminalen Region (Residuen 176-191) des menschlichen Wachstumshormons entspricht und speziell zur Untersuchung des Lipidstoffwechsels isoliert wurde. Das Fragment behält das fettmetabolisierende Signal des Wachstumshormons bei, fehlt jedoch die IGF-1-getriebenen Wachstums- und Glukoseeffekte des intakten Hormons.
| Test | Result | Status |
|---|---|---|
| Purity | 99.16% | Passed ✓ |
Research Information
AOD9604 wird verwendet, um Lipolyse- und Fettoxidationswege in Adipozyten- und Tiermodellen zu untersuchen und die Hypothese zu testen, dass die Wirkung des Wachstumshormons auf Fett von seiner wachstumsfördernden Aktivität getrennt werden kann. Studien untersuchen seinen Einfluss auf den Abbau gespeicherter Triglyceride und sein Fehlen von Wirkung auf IGF-1 und Blutzucker. Wird ausschließlich für In-vitro- und Laborforschungszwecke geliefert — nicht für den menschlichen oder tierischen Verzehr.
AOD9604 Research & Studies
What is AOD9604?
AOD9604 is a synthetic peptide fragment corresponding to the C-terminal region of human growth hormone, specifically residues 176-191 with an N-terminal tyrosine modification. It is employed in laboratory research to examine lipid metabolism signals that can be isolated from the broader activities of intact growth hormone. The compound is designed for investigation of fat-related pathways without the IGF-1-associated growth or glucose effects of the parent molecule. It is supplied strictly for in-vitro and laboratory research use only.
Mechanism of Action
In experimental systems AOD9604 is studied for its capacity to engage pathways linked to lipolysis and fatty-acid oxidation within adipocytes. Research explores how the fragment may promote breakdown of stored triglycerides through signals distinct from those of full-length growth hormone. Investigations focus on the absence of measurable stimulation of IGF-1 production or alterations in blood glucose parameters. These features allow researchers to probe selective metabolic mechanisms in controlled model systems.
Primary Areas of Research
AOD9604 is used to investigate lipolysis and fat-oxidation pathways in adipocyte cultures and animal models. Studies test the hypothesis that growth hormone’s effect on fat can be separated from its growth-promoting activity. Work centers on influence over stored triglyceride breakdown and the lack of concurrent effects on IGF-1 or glucose homeostasis. All investigations remain confined to non-clinical laboratory settings for mechanistic insight.
Key Research Findings
Laboratory models have been employed to assess AOD9604’s influence on triglyceride mobilization in isolated adipocytes. Observations indicate retention of lipolytic signaling alongside no detectable impact on IGF-1 levels or blood glucose in the systems examined. These findings support the concept that the C-terminal fragment can convey fat-metabolizing activity independently of anabolic or hyperglycemic effects. Data are derived exclusively from preclinical experimental preparations.
Research Handling & Considerations
AOD9604 is intended solely for research use and must be handled under standard laboratory peptide protocols. Appropriate cold storage and careful reconstitution are required to preserve structural integrity for experimental work. The material is restricted to in-vitro assays and approved animal model studies and is not for human or animal consumption. Researchers must follow institutional guidelines for documentation and ethical use of research peptides.
Frequently Asked Questions
AOD9604 is studied for lipolysis and fat-oxidation pathways in adipocyte and animal models, testing separation of growth hormone’s fat-metabolizing signals from growth-promoting activity.
Learn more
Read research overviews, COA verification guides, and reconstitution notes in our Knowledge Hub.
Explore Other High-Purity Peptides

Retatrutide

Tirzepatide

Semaglutide
